Claire Wainwright

Professor
Queensland Children’s Hospital, Australia

Poster(s):

• (163) Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in children 6 years and older with cystic fibrosis and ≥1 F508del allele: 96-week interim results from an open-label extension study
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET

• (183) Chest computed tomography scan assessment to monitor cystic fibrosis structural lung disease progression in bronchiectasis over late childhood and adolescence
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET